GSK's Zejula (niraparib) Receives EC's Approval as a Treatment in Advanced Ovarian Cancer

Published: Oct 30, 2020 | Tags: Advanced, Approval, Cancer, EU, GSK, Niraparib, Ovarian, Receives, Treatment, Zejula

AbbVie Reports Results of SKYRIZI (risankizumab) in P-III LIMMitless Study in Patients with Moderate to Severe Plaque Psoriasis

Published: Oct 30,2020 | Tags: AbbVie, LIMMitless, Moderate, P-III, patients, Plaque, Psoriasis, Reports, Results, Risankizumab, Severe, Skyrizi, Study

Sanofi Entered into an Agreement with Merck to Conduct a P-II Study of THOR-707 in Sequenced Administration with MSD's KEYTRUDA® (pembrolizumab) in Patients with Various Cancers

Published: Oct 30, 2020 | Tags: Agreement, Cancers, Clinical Trials, KEYTRUDA, MSD, P-II Study, Sanofi, THOR-707

AstraZenca Reports Results of Fasenra (benralizumab) in P-lllb PONENTE Trial for Asthma

Published: Oct 30, 2020 | Tags: Asthma, AstraZenca, Benralizumab, Fasenra, P-lllb, PONENTE, Trial, Report, Results

Roche's Tecentriq in Combination with Avastin Receives China NMPA's Approval for the Treatment of Unresectable Hepatocellular Carcinoma

Published: Oct 30,2020 | Tags: approval, Avastin, IMbrave150, NMPA, Roche, Sorafenib, Tecentriq, Unresectable Hepatocellular Carcinoma

AstraZenca Expands Supply Agreement with Cheplapharm for Atacand (candesartan cilexetil) and Atacand Plus (candesartan cilexetil + hydrochlorothiazide) to Cheplapharm

Published: Oct 30,2020 | Tags: AstraZenca, Atacand, Atacand Plus, Candesartan cilexetil, Candesartan, cilexetil + Hydrochlorothiazide, Cheplapharm, Expands, Supply Agreement

CStone Signs a License Agreement with LegoChem for LCB71 to Treat Multiple Cancer Indications

Published: Oct 29,2020 | Tags: CStone, LegoChem, License Agreement, New Antibody Drug, Signs

Novartis Acquires Vedere Bio for $280M

Published: Oct 29,2020 | Tags: $280M, Acquire, Novartis, Vedere Bio

BMS Signs a Five-Year Agreement with Insitro to Develop Therapies for ALS and Frontotemporal Dementia

Published: Oct 29,2020 | Tags: Agreement, ALS, BMS, Develop, Five-Year, Frontotemporal Dementia, Insitro, Signs, Therapies

Boehringer Ingelheim Initiates P-II Study of BI 764198 for Patients with Severe Respiratory Illness from COVID-19

Published: Oct 29,2020 | Tags: Boehringer Ingelheim, Clinical, COVID-19, Illness, Initiates, P-II, People, Respiratory, Severe, Targeted, Therapy, Trial

Lilly Reports Results of Bamlanivimab (LY-CoV555) in P-II BLAZE-1 Study in New England Journal of Medicine

Published: Oct 29,2020 | Tags: Bamlanivimab, BLAZE-1, Lilly, LY-CoV555, New England Journal of Medicine, P-II, Reports, Results, Study

Regeneron Reports Results of REGN-COV2 in P-ll/lll Study in Patients with COVID-19 in Outpatient Setting

Published: Oct 29,2020 | Tags: COVID-19, P-ll/lll Trial, Regeneron, REGN-COV2, REGN10933 + REGN10987, Reports, Results

Dermavant Presents Results of Tapinarof in Pivotal P-III PSOARING Program at the 29th EADV Virtual Congress

Published: Oct 28,2020 | Tags: Cream, Data, Dermavant, EADV, P-III, Pivotal, Presents, PSOARING, Results, Tapinarof

Thermo Fisher Expands its Direct-to-Patient Service Offerings

Published: Oct 28, 2020 | Tags: Clinical, Direct, Expand, Offerings, Patient, Service, Thermo Fisher, Trials

Exact Sciences to Acquire Thrive Earlier Detection for ~$2.15B

Published: Oct 28, 2020 | Tags: ~$2.15B, Acquire, Exact Sciences, Thrive Earlier Detection

Sanofi Presents Results of Olipudase Alfa in Two Clinical Studies at ASHG 2020

Published: Oct 28,2020 | Tags: ASMD, Function, Improvement, Lung, Olipudase alfa, Patients, Reports, Results, Sanofi, Spleen, Volume

Novartis Signs an Option and License Agreement with Molecular Partners to Develop Two DARPin Therapies for COVID-19

Published: Oct 28,2020 | Tags: COVID-19, DARPin Therapies, Develop, License Agreement, Molecular Partners, Novartis, Option, Signs, Two

AstraZeneca's Forxiga (dapagliflozin) Receive NMPA's Approval for Label Update to Include Data of P-III DECLARE-TIMI 58 Study

Published: Oct 28, 2020 | Tags: Approval, AstraZeneca, Dapagliflozin, DECLARE-TIMI, 58 Forxiga, Include, Label, NMPA, P-III, Receives, Results, Trial, Update

Samsung Bioepis Reports Results of Renflexis (biosimilar, infliximab) from Two Studies in IBD Patients

Published: Oct 27, 2020 | Tags: 2020, ACG, Affairs, Healthcare, IBD, infliximab-abda, patients, RENFLEXIS, Reports, Results, Samsung Bioepis, Studies, System, Two, Veterans

Medtronic's Abre Venous Stent Receives the US FDA's Approval to Treat Venous Outflow Obstruction

Published: Oct 27,2020 | Tags: approval, Medtronic, Obstruction, Outflow, Receives, Stent, Treat, US FDA, Venous

Novartis Presents Results of Iptacopan (LNP023) in P-ll Study for C3 Glomerulopathy at ASN Annual Meeting 2020

Published: Oct 27, 2020 | Tags: ASN Annual Meeting 2020, C3 Glomerulopathy (C3G), Iptacopan, Novartis, P-ll Study, Result

Sanofi and Regeneron Report Results of Dupixent (dupilumab) in Part A of P-lll Study for Eosinophilic Esophagitis (EoE)

Published: Oct 27, 2020 | Tags: dupilumab, Dupixent, EoE, P-lll Study, Regeneron, Reports, Results, Virtual ACG 2020 and UEG Week 2020

CStone Signs an Out-Licensing Agreement with EQRx for Sugemalimab and CS1003

Published: Oct 27, 2020 | Tags: CS1003 (anti-PD-1), CStone, EQRx, Out-Licensing Agreement, Signs, Sugemalimab (anti-PD-L1), Targeted Indication

Jazz Pharmaceuticals Acquires SpringWorks' FAAH Inhibitor Program for Post-Traumatic Stress Disorder

Published: Oct 27,2020 | Tags: Acquires, FAAH Inhibitor Program, Jazz Pharmaceutical, SpringWorks Therapeutics

AstraZeneca Presents Results of Farxiga (dapagliflozin) in P-lll DAPA-CKD Study for Chronic Kidney Disease at ASN Kidney Week 2020

Published: Oct 26,2020 | Tags: AstraZeneca, CKD, DAPA-CKD Study, Dapagliflozin, Farxiga, P-lll, Result

Boehringer Ingelheim and Eli Lilly Report Results of Jardiance in Adults with HFrEF Regardless of Chronic Kidney Disease Status

Published: Oct 26,2020 | Tags: Adults, Boehringer Ingelheim, Chronic Disease, Eli Lilly, HFrEF, Jardiance, Kidney, Regardless, Reports, Results, Status

AstraZeneca Resumes P-III Study of AZD1222 Against COVID-19 in the US

Published: Oct 26,2020 | Tags: Against, AstraZeneca, AZD1222, COVID-19, P-III, Resumes, Study, US

Eisai and Cogstate Expand their Agreement to Develop and Commercialize Digital Cognitive Assessment Technologies

Published: Oct 26,2020 | Tags: Agreement, Cogstate, Digital Cognitive Assessment Technologies, Eisai, Expand

Bayer Acquires Asklepios for ~$4B

Published: Oct 26, 2020 | Tags: (AskBio), ~$4B, Acquires, Asklepios BioPharmaceutical, Bayer

Foundation Medicine's FoundationOne CDx Receives the US FDA's Approval as a CDx for Vitrakvi (larotrectinib)

Published: Oct 26, 2020 | Tags: Across, ALL, approval, Companion, Diagnostic, Foundation Medicine, FoundationOne CDx, Fusions, Identify, Larotrectinib, NTRK, Patients, Receives, Solid, Tumors, U.S.FDA, Vitrakvi